Literature DB >> 20851232

A randomized, double-blind, noninferiority study to compare two regimens of levonorgestrel for emergency contraception in Nigeria.

Olukayode A Dada1, Emily M Godfrey, Gilda Piaggio, Helena von Hertzen.   

Abstract

BACKGROUND: Unplanned pregnancies are common in Nigeria. Much of the unplanned pregnancies is due to low contraceptive prevalence and high contraceptive user failure rates. High user failure rates suggest the important role of emergency contraception to prevent unplanned pregnancy. STUDY
DESIGN: Randomized, controlled, double-blind, multicenter, noninferiority trial comparing efficacy and side effects of two emergency contraceptive regimens up to 5 days after unprotected intercourse among 3022 Nigerian women: levonorgestrel administered in two doses of 0.75 mg given 12 h apart and levonorgestrel administered in a single dose of 1.5 mg.
RESULTS: Efficacy was similar between the treatment groups; post-treatment pregnancy proportions were 0.57% in the two-dose regimen vs. 0.64% in the single-dose regimen (risk difference 0.07% (95% CI -0.50 to 0.64). The majority of women menstruated the first day of expected menses and the groups did not differ regarding reported side effects.
CONCLUSIONS: This study shows the simplified emergency contraceptive regimen of single-dose levonorgestrel is not inferior in efficacy to the two-dose regimen among Nigerian women.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20851232     DOI: 10.1016/j.contraception.2010.06.004

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  13 in total

Review 1.  A Systematic Review and Meta-analysis of the Adverse Effects of Levonorgestrel Emergency Oral Contraceptive.

Authors:  Nattawut Leelakanok; Janthima Methaneethorn
Journal:  Clin Drug Investig       Date:  2020-05       Impact factor: 2.859

Review 2.  Emergency contraception review: evidence-based recommendations for clinicians.

Authors:  Kelly Cleland; Elizabeth G Raymond; Elizabeth Westley; James Trussell
Journal:  Clin Obstet Gynecol       Date:  2014-12       Impact factor: 2.190

Review 3.  Safety and effectiveness data for emergency contraceptive pills among women with obesity: a systematic review.

Authors:  Tara C Jatlaoui; Kathryn M Curtis
Journal:  Contraception       Date:  2016-05-24       Impact factor: 3.375

4.  Access to Emergency Contraception in the Over-the-Counter Era.

Authors:  Kelly Cleland; Jamie Bass; Florida Doci; Angel M Foster
Journal:  Womens Health Issues       Date:  2016-09-24

Review 5.  Interventions for emergency contraception.

Authors:  Jie Shen; Yan Che; Emily Showell; Ke Chen; Linan Cheng
Journal:  Cochrane Database Syst Rev       Date:  2017-08-02

6.  A Randomized, Controlled Trial of Levonorgestrel Vs. The Yuzpe Regimen as Emergency Contraception Method among Iranian Women.

Authors:  Fatemeh Sadat Hoseini; Mohammad Eslami; Mohammed Abbasi; Fatemeh Noroozi Fashkhami; Soheila Besharati
Journal:  Iran J Public Health       Date:  2013-10       Impact factor: 1.429

Review 7.  Recent advances in contraception.

Authors:  Abigail R A Aiken; James Trussell
Journal:  F1000Prime Rep       Date:  2014-12-01

8.  Interventions for emergency contraception.

Authors:  Jie Shen; Yan Che; Emily Showell; Ke Chen; Linan Cheng
Journal:  Cochrane Database Syst Rev       Date:  2019-01-20

Review 9.  A systematic review of effectiveness and safety of different regimens of levonorgestrel oral tablets for emergency contraception.

Authors:  Mohammad Shohel; Mohammad Mahfuzur Rahman; Asif Zaman; Mir Muhammad Nasir Uddin; Md Mamun Al-Amin; Hasan Mahmud Reza
Journal:  BMC Womens Health       Date:  2014-04-04       Impact factor: 2.809

10.  A prospective, open-label, single arm, multicentre study to evaluate efficacy, safety and acceptability of pericoital oral contraception using levonorgestrel 1.5 mg.

Authors:  Mario P R Festin; Luis Bahamondes; Thi My Huong Nguyen; Ndema Habib; Manopchai Thamkhantho; Kuldip Singh; Arundhati Gosavi; Gyorgy Bartfai; Tamas Bito; M Valeria Bahamondes; Nathalie Kapp
Journal:  Hum Reprod       Date:  2016-01-31       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.